Skip to main content
SpringerLink
Log in

Pharmacokinetics of Zidovudine and Metabolites in a Patient with HIV-Associated Nephropathy and Severe Renal Impairment

  • Case Report
  • Published:
Drug Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Blum MR, Liao SHT, Good SS, De Miranda P. Pharmacokinetics and bioavailability of zidovudine in humans. American Journal of Medicine 85 (Suppl. 2A): 189–194, 1988

    PubMed  CAS  Google Scholar 

  • Burger DM, Meenhorst PL, Koks CHW, Beijnen JH. Drug interactions with zidovudine. AIDS 7: 445–460, 1993a

    Article  PubMed  CAS  Google Scholar 

  • Burger DM, Rosing H, Koopman FJ, et al. Determination of 3′-amino-3′-deoxythymidine, a cytotoxic metabolite of 3′-azido-3′-deoxythymidine, in human plasma by ion-pair high performance liquid chromatography. Journal of Chromatography (Biomedical Applications) 622: 235–242, 1993b

    Article  CAS  Google Scholar 

  • Cretton EM, Xie M-Y, Bevan RJ, Goudgaon NM, Schinazi RF, et al. Catabolism of 3′-azido-3′-deoxythymidine in hepatocytes and liver microsomes, with evidence of formation of 3′-amino-3′-deoxythymidine, a highly toxic catabolite for human bone marrow cells. Molecular Pharmacology 39: 258–266, 1991

    PubMed  CAS  Google Scholar 

  • Deray G, Diquet B, Martinez F, Vidal AM, Petitclerc T, et al. Pharmacokinetics of zidovudine in a patient on maintenance haemodialysis [Letter]. New England Journal of Medicine 319: 1606–1607, 1988

    Article  PubMed  CAS  Google Scholar 

  • Ersley AJ. Erythropoietin. New England Journal of Medicine 324: 1339–1344, 1991

    Article  Google Scholar 

  • Gallicano KD, Tobe S, Sahai J, McGilveray IJ, Cameron DW, et al. Pharmacokinetics of single and chronic dose zidovudine in two HIV-positive patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Journal of Acquired Immune Deficiency Syndromes 5: 242–250, 1992

    PubMed  CAS  Google Scholar 

  • Gibaldi M. Biopharmaceutics and clinical pharmacokinetics. 4th Edition, pp. 14–23, Lea & Febiger, Philadelphia, 1991

    Google Scholar 

  • Glassock RJ (moderator). Human immunodeficiency virus (HIV) infection and the kidney. Annals of Internal Medicine 112: 35–49, 1990

    PubMed  CAS  Google Scholar 

  • Henry DH, Beall GN, Benson CA, Carey J, Cone LA, et al. Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials. Annals of Internal Medicine 117: 739–748, 1992

    PubMed  CAS  Google Scholar 

  • Howe JL, Back DJ, Colbert J. Extrahepatic metabolism of zidovudine. British Journal of Clinical Pharmacology 33: 190–192, 1992

    Article  PubMed  CAS  Google Scholar 

  • Klecker RW, Collins JM, Yarchoan R, Thomas R, Jenkins JF, et al. Plasma and cerebrospinal fluid pharmacokinetics of 3′-azido-3′-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases. Clinical Pharmacology and Therapeutics 41: 407–412, 1987

    Article  PubMed  Google Scholar 

  • Kremer D, Munar MY, Kohlhepp SJ, Swan SK, Stinnett EA, et al. Zidovudine pharmacokinetics in five HIV seronegative patients undergoing continuous ambulatory peritoneal dialysis. Pharmacotherapy 21: 56–60, 1992

    Google Scholar 

  • McLeod GX, Hammer SM. Zidovudine: five years later. Annals of Internal Medicine 117: 487–501, 1992

    PubMed  CAS  Google Scholar 

  • Michel C, Dosquet P, Ronco P, Mougenot B, Viron B, et al. Nephropathy associated with infection by human immunodeficiency virus: a report on 11 cases including 6 treated with zidovudine. Nephron 62: 434–440, 1992

    Article  PubMed  CAS  Google Scholar 

  • Morse GD, Shelton MJ, O’Donnell AM. Comparative pharmacokinetics of antiviral nucleoside analogues. Clinical Pharmacokinetics 24: 101–123, 1993

    Article  PubMed  CAS  Google Scholar 

  • Pachon J, Cisneros JM, Castillo JR, Garcia-Pesquera F, Canas E, et al. Pharmacokinetics of zidovudine in end-stage renal disease: influence of haemodialysis. AIDS 6: 827–830, 1992

    Article  PubMed  CAS  Google Scholar 

  • Paoli I, Dave M, Cohen B. Pharmacodynamics of zidovudine in patients with end-stage renal disease [Letter]. New England Journal of Medicine 326: 839–840, 1992

    Article  PubMed  CAS  Google Scholar 

  • Rachlis A, Fanning MM. Zidovudine toxicity. Clinical features and management. Drug Safety 8: 312–320, 1993

    Article  PubMed  CAS  Google Scholar 

  • Singlas E, Pioger J-C, Taburet A-M, Colin J-N, Fillastre J-P. Zidovudine disposition in patients with severe renal impairment: influence of haemodialysis. Clinical Pharmacology and Therapeutics 46: 190–197, 1989

    Article  PubMed  CAS  Google Scholar 

  • Spivak JL, Barnes DC, Fuchs E, Quinn TC. Serum immunoreactive erythropoietin in HIV-infected patients. Journal of the American Medical Association 261: 3104–3107, 1989

    Article  PubMed  CAS  Google Scholar 

  • Stagg MP, Cretton EM, Kidd L, Diasio RB, Sommadossi J-P. Clinical pharmacokinetics of 3′-azido-3′deoxythymidine (zidovudine) and catabolites with formation of a toxic catabolite, 3′-amino-3′-deoxythymidine. Clinical Pharmacology and Therapeutics 51: 668–676, 1992

    Article  PubMed  CAS  Google Scholar 

  • Stellbrink H-J, Averdunk R, Stoehr A, Albrecht H. Zidovudine half-life in haemodialysis patients [Letter]. AIDS 7: 141–142, 1993

    Article  PubMed  CAS  Google Scholar 

  • Tadepalli SM, Puckett L, Jeal S, Kanis L, Quinn RP. Differential assay of zidovudine and its glucuronide metabolite in serum and urine with a radioimmunoassay kit. Clinical Chemistry 36: 897–900, 1990

    PubMed  CAS  Google Scholar 

  • Touchette MA, Slaughter RL. The effect of renal failure on hepatic drug clearance. DICP, The Annals of Pharmacotherapy 25: 1214–1224, 1991

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacy, Slotervaart Hospital, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands

    D. M. Burger, C. H. W. Koks & J. H. Beijnen

  2. Department of Internal Medicine, Slotervaart Hospital, Amsterdam, The Netherlands

    P. L. Meenhorst & J. W. Mulder

  3. Utrecht University, Utrecht, The Netherlands

    A. Bult (Faculty of Pharmacy)

Authors
  1. D. M. Burger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. L. Meenhorst
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. W. Mulder
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. H. W. Koks
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Bult
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. H. Beijnen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Burger, D.M., Meenhorst, P.L., Mulder, J.W. et al. Pharmacokinetics of Zidovudine and Metabolites in a Patient with HIV-Associated Nephropathy and Severe Renal Impairment. Drug Invest 7, 282–287 (1994). https://doi.org/10.1007/BF03257420

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03257420

Keywords

Search

Navigation